Cybersecurity Firms Gain Three-Tier Access to Anthropic’s Claude Mythos and Latest ModelsOctober 7, 2026
How Professional Crypto Traders Use Multiple Exchanges to Arbitrage Execution, Not Just PriceJune 1, 2026
Stock Workday (WDAY) Stock: Slightly Soars as Profit Surges and Backlog Hits $28BBy Yasmin WernerFebruary 24, 2026
Stock HP Inc. (HPQ)Stock: Cash Flow Improves as Market Reacts to Soft EPS GuidanceBy Yasmin WernerFebruary 24, 2026
Stock Intel (INTC) Stock: Jumps 5% on Major AI Investment and SambaNova PartnershipBy Yasmin WernerFebruary 24, 2026
Stock Lucid (LCID) Stock: Soars on Record Deliveries, 123% Revenue Surge and Strong 2026 OutlookBy Yasmin WernerFebruary 24, 2026
Stock AMD (AMD) Stock: Surge Fueled by Meta’s $100B Chip Deal and 6GW AI BuildoutBy Yasmin WernerFebruary 24, 2026
Stock Intuit (INTU) Stock: Surges on Game-Changing AI Partnership With AnthropicBy Yasmin WernerFebruary 24, 2026
SoundHound AI (SOUN) Stock: Gains 6% as New Sales Assist Agent Launches at MWC 2026By Yasmin WernerFebruary 24, 2026
Stock Medtronic plc (MDT) Stock: Slips as MiniMed Targets $7.86B IPO ValuationBy Yasmin WernerFebruary 24, 2026
Stock Ten-League International Holdings (TLIH) Stock: Infrastructure Momentum Lifts Revenue and Profit ForecastsBy Yasmin WernerFebruary 24, 2026
Stock Iovance (IOVA) Stock: Early UPS and DDLPS Results Signal Major Immunotherapy OpportunityBy Yasmin WernerFebruary 24, 2026
Stock NVIDIA Corporation (NVDA) Stock: Gains Momentum While Institutional Ownership Gap WidensBy Yasmin WernerFebruary 24, 2026
Stock Billionaire David Tepper Sells Nvidia and AMD Stock to Buy Alphabet, Meta, and MicrosoftBy Ken CareyFebruary 24, 2026
Stock Keysight (KEYS) Stock Surges 24% on Strong Orders and Raised GuidanceBy Ken CareyFebruary 24, 2026
Stock Taiwan Semiconductor (TSM) Stock Hits New 52 Week High – What’s Driving the Rally?By Ken CareyFebruary 24, 2026
Stock Ford Motor (F) Stock — Ford Recalls 412,774 Explorer SUVs Over Suspension FaultBy Ken CareyFebruary 24, 2026
Stock Hims & Hers (HIMS) Stock: Drops 6% After Q1 Revenue Outlook Falls ShortBy Ken CareyFebruary 24, 2026
Stock Iovance Biotherapeutics (IOVA) Stock Surges 27% After Q4 2025 Revenue BeatBy Ken CareyFebruary 24, 2026
